Insider · CIK 0001564926
Patrick R. O'Neil
officer
Files at IONS (IONIS PHARMACEUTICALS INC). First filing Jan 17, 2025, latest Jun 30, 2026.
In brief
Patrick R. O'Neil files SEC Form 4 as officer at IONS (IONIS PHARMACEUTICALS INC). Since Jan 17, 2025, Patrick R. O'Neil has reported 0 open-market buys worth $0 and 14 open-market sells worth $17M, the latest filed on Jun 30, 2026.
A track record needs three past buys with six months of prices behind them; Patrick R. O'Neil has 0, so none is measured yet.
The newest scored trade: sold $246k of IONS on Jun 26, 2026, filed Jun 30, 2026, scored 23 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $2.2M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 14
$0 bought, $17M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IONS: IONIS PHARMACEUTICALS INC
IONSOct 9, 2026 · close 45.28
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | IONIS PHARMACEUTICALS INC | $246k 3,069 shares | -5% | +105% from low-6% from high | |
| 37Weak | IONIS PHARMACEUTICALS INC | $764k 10,148 shares | -14% | +195% from low-13% from high | |
| 48Moderate | IONIS PHARMACEUTICALS INC | $516k 6,179 shares | -8% | +224% from low-1% from high | |
| 41Moderate | IONIS PHARMACEUTICALS INC | $697k 9,191 shares | -12% | +199% from low-8% from high | |
| 24Weak | IONIS PHARMACEUTICALS INC | $937k 13,441 shares | -20% | +171% from low-0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $4.4M 64,664 shares | -74% | +168% from low0% from high | |
| 30Weak | IONIS PHARMACEUTICALS INC | $1.6M 25,300 shares | -37% | +151% from low-0% from high | |
| 5Weak | IONIS PHARMACEUTICALS INC | $110k 1,700 shares | -3% | +148% from low-2% from high | |
| 30Weak | IONIS PHARMACEUTICALS INC | $1.4M 21,000 shares | -27% | +152% from low0% from high | |
| 40Moderate | IONIS PHARMACEUTICALS INC | $5.4M 89,900 shares | -128% | +125% from low0% from high | |
| 1Weak | IONIS PHARMACEUTICALS INC | $39k 1,207 shares | -2% | - | |
| 22Weak | IONIS PHARMACEUTICALS INC | $195k 6,165 shares | -10% | - | |
| 36Weak | IONIS PHARMACEUTICALS INC | $46k 1,406 shares | -2% | - | |
| 33Weak | IONIS PHARMACEUTICALS INC | $242k 7,360 shares | -11% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | 3,069 0.00% of outstanding | $246k | Jun 26, 2026 | none |
| Mar 9, 2026 | IONS IONIS PHARMACEUTICALS INC | 13,217 0.01% of outstanding | $995k | Mar 9, 2026 | $1.2M |
| Jan 30, 2026 | IONS IONIS PHARMACEUTICALS INC | 6,179 0.00% of outstanding | $513k | Jan 30, 2026 | $697k |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | 9,191 0.01% of outstanding | $701k | Jan 16, 2026 | none |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | 78,105 0.05% of outstanding | $5.3M | Oct 2, 2025 | $8.5M |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | 124,850 0.08% of outstanding | $7.6M | Sep 3, 2025 | $711k |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | 13,050 0.01% of outstanding | $711k | Sep 2, 2025 | none |
| Feb 4, 2025 | IONS IONIS PHARMACEUTICALS INC | 7,372 0.00% of outstanding | $237k | Feb 4, 2025 | $67k |
| Jan 31, 2025 | IONS IONIS PHARMACEUTICALS INC | 1,910 0.00% of outstanding | $67k | Jan 31, 2025 | $242k |
| Jan 16, 2025 | IONS IONIS PHARMACEUTICALS INC | 7,360 0.00% of outstanding | $241k | Jan 16, 2025 | none |
| Dec 27, 2023 | IONS IONIS PHARMACEUTICALS INC | 20,825 0.01% of outstanding | $1.1M | Dec 26, 2023 | none |
Transactions
The newest 50 of 60 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +63 | $51.31 | $3,232 | 59,205 | 41 d ago |
| Jun 26, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -3,069 | $80.00 | $246k | 61,470 | Jun 30, 2026 |
| Mar 9, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -10,148 | $75.25 | $764k | 62,211 | Mar 11, 2026 |
| Feb 27, 2026 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +376 | $48.87 | $18k | 72,359 | Mar 3, 2026 |
| Jan 29, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Common Stock | +11,991 | $0.00 | $0 | 78,162 | Feb 2, 2026 |
| Jan 30, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -6,179 | $83.53 | $516k | 71,983 | Feb 2, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock | +21,473 | $0.00 | $0 | 75,362 | Jan 20, 2026 |
| Jan 16, 2026 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock | -9,191 | $75.84 | $697k | 66,171 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Performance Restricted Stock Unitsderivative | +25,800 | $0.00 | $0 | 90,601 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Restricted Stock Unitderivative | -21,473 | $0.00 | $0 | 39,251 | Jan 20, 2026 |
| Jan 15, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Restricted Stock Unitderivative | +9,675 | $0.00 | $0 | 48,926 | Jan 20, 2026 |
| Jan 2, 2026 | IONS IONIS PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +19,350 | $0.00 | $0 | 19,350 | Jan 6, 2026 |
| Oct 6, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +10,200 | $52.87 | $539k | 67,330 | Oct 8, 2025 |
| Oct 6, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -10,200 | $69.89 | $713k | 57,130 | Oct 8, 2025 |
| Oct 6, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -3,241 | $69.27 | $224k | 53,889 | Oct 8, 2025 |
| Oct 6, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -10,200 | $0.00 | $0 | 17,000 | Oct 8, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +30,203 | $56.78 | $1.7M | 87,333 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -30,203 | $67.69 | $2.0M | 57,130 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +34,461 | $60.89 | $2.1M | 91,591 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -34,461 | $67.69 | $2.3M | 57,130 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -30,203 | $0.00 | $0 | 0 | Oct 2, 2025 |
| Oct 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -34,461 | $0.00 | $0 | 0 | Oct 2, 2025 |
| Sep 29, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +10,473 | $56.78 | $595k | 67,603 | Oct 1, 2025 |
| Sep 29, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -10,473 | $64.54 | $676k | 57,130 | Oct 1, 2025 |
| Sep 30, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +14,827 | $56.78 | $842k | 71,957 | Oct 1, 2025 |
| Sep 30, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -14,827 | $64.68 | $959k | 57,130 | Oct 1, 2025 |
| Sep 29, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -10,473 | $0.00 | $0 | 45,030 | Oct 1, 2025 |
| Sep 30, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -14,827 | $0.00 | $0 | 30,203 | Oct 1, 2025 |
| Sep 12, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +1,700 | $56.78 | $97k | 58,830 | Sep 16, 2025 |
| Sep 12, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,700 | $64.58 | $110k | 57,130 | Sep 16, 2025 |
| Sep 12, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,700 | $0.00 | $0 | 55,503 | Sep 16, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +20,000 | $60.89 | $1.2M | 77,130 | Sep 11, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -20,000 | $64.56 | $1.3M | 57,130 | Sep 11, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +1,000 | $56.78 | $57k | 58,130 | Sep 11, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,000 | $64.56 | $65k | 57,130 | Sep 11, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -1,000 | $0.00 | $0 | 57,203 | Sep 11, 2025 |
| Sep 9, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 34,461 | Sep 11, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +13,050 | $32.60 | $425k | 70,180 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -13,050 | $54.51 | $711k | 57,130 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +14,000 | $37.58 | $526k | 71,130 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -65,475 | $60.89 | $4.0M | 5,655 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +13,050 | $32.60 | $425k | 18,705 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -11,375 | $61.42 | $699k | 7,330 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Common Stock10b5-1 | +49,800 | $53.77 | $2.7M | 57,130 | Sep 4, 2025 |
| Sep 2, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -13,050 | $0.00 | $0 | 17,517 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -13,050 | $0.00 | $0 | 4,467 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -14,000 | $0.00 | $0 | 8,942 | Sep 4, 2025 |
| Sep 3, 2025 | IONS IONIS PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -49,800 | $0.00 | $0 | 0 | Sep 4, 2025 |
| Aug 29, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +331 | $27.71 | $9,172 | 57,130 | Sep 3, 2025 |
| Feb 28, 2025 | IONS IONIS PHARMACEUTICALS INC | JOther Common Stock | +554 | $28.21 | $16k | 56,799 | Mar 4, 2025 |
50 of 60 rows shown.
Questions about Patrick R. O'Neil
Answered from the filings on this page, as of the latest one.
Is Patrick R. O'Neil buying or selling?
In the last 12 months Patrick R. O'Neil reported 0 open-market buys worth $0 and 4 open-market sells worth $2.2M on SEC Form 4; the latest was sold $246k of IONS on Jun 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Patrick R. O'Neil's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick R. O'Neil has 0.
Where does Patrick R. O'Neil file Form 4?
Patrick R. O'Neil has filed Form 4 at IONS (IONIS PHARMACEUTICALS INC) as EVP CLO & General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.